Bio-Rad Laboratories Inc (BIO)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	1,380,088	1,403,988	1,383,768	1,390,532	1,426,483	1,457,680	1,495,789	1,529,287	1,570,430	1,574,334	1,637,977	1,643,594	1,640,661	1,699,815	1,629,691	1,521,081	1,437,822	1,308,106	1,247,821	1,262,602
Revenue (ttm)	US$ in thousands	2,566,525	2,580,209	2,562,604	2,605,238	2,671,262	2,720,366	2,769,042	2,779,031	2,802,249	2,804,730	2,870,979	2,895,811	2,922,545	2,979,615	2,879,829	2,700,778	2,545,626	2,380,215	2,293,585	2,329,324
Gross profit margin		53.77%	54.41%	54.00%	53.37%	53.40%	53.58%	54.02%	55.03%	56.04%	56.13%	57.05%	56.76%	56.14%	57.05%	56.59%	56.32%	56.48%	54.96%	54.40%	54.20%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $1,380,088K ÷ $2,566,525K
= 53.77%

The gross profit margin of Bio-Rad Laboratories Inc has shown a fluctuating trend over the period from March 31, 2020, to December 31, 2024. The margin started at 54.20% in March 2020, increased gradually, peaking at 57.05% in September 2021, and then decreased to 53.40% by December 31, 2023. It slightly recovered to 54.41% by September 30, 2024, but decreased again to 53.77% by the end of December 31, 2024.

Overall, the gross profit margin of Bio-Rad Laboratories Inc has demonstrated some variability, potentially influenced by factors such as changes in revenue, cost of goods sold, and pricing strategies. It is essential for stakeholders to monitor this key metric closely to assess the company's ability to manage production costs and maintain profitability.